1. Romero-Gómez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol 2015; 62:437-447.
2. Tripodi V, Contin M, Fernández MA, Lemberg A. Bile acids content in brain of common duct ligated rats. Ann Hepatol 2012; 11:930-934.
3. Cai SY, Lionarons DA, Hagey L, Soroka CJ, Mennone A, Boyer JL. Adult sea lamprey tolerates biliary atresia by altering bile salt composition and renal excretion. Hepatology 2013;57: 2418-2426.
4. Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, et al. The effect of inflammatory cytokines in alcoholic liver disease. Mediators inflamma 2013; 2013: 1-10.
5. Nguyen KD, Sundaram V, Ayoub WS. Atypical causes of cholestasis. World J Gastroenterol: WJG 2014; 20:9418-9426.
6. Perez MJ, Briz O. Bile-acid-induced cell injury and protection World J Gastroenterol: WJG 2009; 15:1677-1689.
7. Thébaut A, Debray D, Gonzales E. An update on the physiopathology and therapeutic management of cholestatic pruritus in children. Clin Res Hepatol Gastroenterol 2018; 42:103-109.
8. Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol 2016; 4:131-142.
9. Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 2010:369-405.
10.Cichoż-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol: WJG 2013; 19:26-34.
11. Rao KVR, Jayakumar AR, Norenberg MD. Brain edema in acute liver failure: mechanisms and concepts. Metab Brain Dis 2014; 29:927-936.
12. Petersen PE. The world oral health report 2003: continuous improvement of oral health in the 21st century–the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol 2003; 31:3-24.
13. Zhang J, Xu L, Zhang L, Ying Z, Su W, Wang T. Curcumin attenuates d-galactosamine/lipopolysaccharide–induced liver injury and mitochondrial dysfunction in mice. J Nutr 2014; 144:1211-1218.
14. Fan Z, Jing H, Yao J, Li Y, Hu X, Shao H, et al. The protective effects of curcumin on experimental acute liver lesion induced by intestinal ischemia-reperfusion through inhibiting the pathway of NF-κB in a rat model. Oxid Med Cell Longev 2014; 2014 1-8
15. Kuo C-P, Lu C-H, Wen L-L, Cherng C-H, Wong C-S, Borel CO, et al. Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage. Anesthesiology 2011; 115:1229-1238.
16. Wang L, Li X, Chen C. Inhibition of acetaminophen-induced hepatotoxicity in mice by exogenous thymosinβ4 treatment. Int Immunopharmacol 2018; 61:20-28.
17. Zhao J, Yu S, Zheng W, Feng G, Luo G, Wang L, et al. Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res 2010; 35:374-379.
18. Olteanu D, Filip A, Mureşan A, Nagy A, Tabaran F, Moldovan R, et al. The effects of chitosan and low dose dexamethasone on extrahepatic cholestasis after bile duct ligation in Wistar rats. Acta Physiol Hung 2012; 99:61-73.
19. Dehghan F, Hadad MK, Asadikram G, Najafipour H, Shahrokhi N. Effect of melatonin on intracranial pressure and brain edema following traumatic brain injury: role of oxidative stresses. Arch Med Res 2013; 44:251-258.
20. Amiresmaili S, Khaksari M, Shahrokhi N, Abolhassani M. Evolution of TLR4 role in mediating the hepatoprotective effects of estradiol after traumatic brain injury in male rats. Biochem Pharmacol 2020; 178:114044.
21. Maghool F, Khaksari M. Differences in brain edema and intracranial pressure following traumatic brain injury across the estrous cycle: involvement of female sex steroid hormones. Brain Res 2013; 1497:61-72.
22. Dhanda S, Sandhir R. Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Behav Brain Res 2015; 286:222-235.
23. Farrell M, Aherne S, O’Riordan S, O’Keeffe E, Greene C, Campbell M. Blood-brain barrier dysfunction in a boxer with chronic traumatic encephalopathy and schizophrenia. Clin Neuropathol 2019; 38:51.
24. Jayakumar A, Valdes V, Tong X, Shamaladevi N, Gonzalez W, Norenberg MD. Sulfonylurea receptor 1 contributes to the astrocyte swelling and brain edema in acute liver failure. Transl Stroke Res2014; 5:28-37.
25. Monfort P, Cauli O, Montoliu C, Rodrigo R, Llansola M, Piedrafita B, et al. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications. Neurochem Int 2009; 55:106-112.
26. Kawai H, Ishibashi T, Kudo N, Kawashima Y, Mitsumoto A. Behavioral and biochemical characterization of rats treated chronically with thioacetamide: proposal of an animal model for hepatic encephalopathy associated with cirrhosis. J Toxicol Sci 2012; 37:1165-1175.
27. Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007; 46:1844-1852.
28. Badria FA, Ibrahim AS, Badria AF, Elmarakby AA. Curcumin attenuates iron accumulation and oxidative stress in the liver and spleen of chronic iron-overloaded rats. PLoS One 2015; 10: e0134156.
29. Tokaç M, Taner G, Aydın S, Özkardeş AB, Dündar HZ, Taşlıpınar MY, et al. Protective effects of curcumin against oxidative stress parameters and DNA damage in the livers and kidneys of rats with biliary obstruction. Food Chem Toxicol 2013; 61:28-35.
30. Varatharajalu R, Garige M, Leckey LC, Reyes-Gordillo K, Shah R, Lakshman MR. Protective role of dietary curcumin in the prevention of the oxidative stress induced by chronic alcohol with respect to hepatic injury and antiatherogenic markers. Oxid Med Cell Longev 2016; 2016.
31. Shapiro, H., Ashkenazi, M., Weizman, N., Shahmurov, M., Aeed, H., Bruck, R. Curcumin ameliorates acute thioacetamide‐induced hepatotoxicity. J Gastroenterol Hepatol 2006; 21: 358–366.
32. Mpabanzi L, Jalan R. Neurological complications of acute liver failure: pathophysiological basis of current management and emerging therapies. Neurochem Int 2012; 60:736-742.
33. Wright G, Shawcross D, Damink SWO, Jalan R. Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab Brain Dis 2007; 22:375-388.
34. Zhu H-t, Bian C, Yuan J-c, Chu W-h, Xiang X, Chen F, et al. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury. J Neuroinflammation 2014 ; 11 :1-17.
35. Qi Z, Zhang H, Fu C, Liu X, Chen B, Dang Y, et al. Prolonged hydrocephalus induced by intraventricular hemorrhage in rats is reduced by curcumin therapy. Neurosci Lett 2017; 637:120-125.
36. Laird MD, Sukumari-Ramesh S, Swift AE, Meiler SE, Vender JR, Dhandapani KM. Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4? J Neurochem 2010; 113:637-648.
37.Dairam A, Fogel R, Daya S, Limson JL. Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. J Agric Food Chem 2008; 56:3350-3356.
38. Thal SC, Neuhaus W. The blood–brain barrier as a target in traumatic brain injury treatment. Arch Med Res 2014; 45:698-710.
39. Sepehrinezhad A, Zarifkar A, Namvar G, Shahbazi A, Williams R. Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema. Metab Brain Dis 2020; 35:559-578.
40. Qi Zahihua, Zhang H, Fu C, Liu X, Chen B, Dang Y, et al. Prolonged hydrocephalus induced by intraventricular hemorrhage in rats is reduced by curcumin therapy. Neurosci Lett 2017; 637:120-125.
41. Jiang J, Wang W, Sun YJ, Hu M, Li F, Zhu DY. Neuroprotective effect of Curcumin on focal cerebral ischemic rats by preventing blood–brain barrier damage. Eur J Pharmacol 2007; 561:54-62.
42. King MD, McCracken DJ, Wade FM, Meiler SE, Alleyne Jr CH, Dhandapani KM. Attenuation of hematoma size and neurological injury with Curcumin following intracerebral hemorrhage in mice. J Neurosurg 2011; 115:116-123.
43. Yuan J, Liu W, Zhu H, Zhang X, Feng Y, Chen Y, et al. Curcumin attenuates blood-brain barrier disruption after subarachnoid hemorrhage in mice. J Surg Res 2017; 207:85-91.
44. Zhang Z-y, Jiang M, Fang J, Yang M-f, Zhang S, Yin Y-x, et al. Enhanced therapeutic potential of nano-curcumin against subarachnoid hemorrhage-induced blood–brain barrier disruption through inhibition of inflammatory response and oxidative stress. Mol Neurobiol 2017; 54:1-14.
45. Yu LS, Fan YY, Ye G, Li J, Feng XP, Lin K, et al. Curcumin alleviates brain edema by lowering AQP4 expression levels in a rat model of hypoxia-hypercapnia-induced brain damage. Exp Ther Med 2016; 11:709-716.